3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
19
Lymphoma
17
Lymphoma, Large B-Cell, Diffuse
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Lymphoma, Non-Hodgkin
14
Hodgkin Disease
13
Multiple Myeloma
12
Lymphoma, Mantle-Cell
12
Lymphoma, Follicular
12
Carcinoma, Non-Small-Cell Lung
11
Breast Neoplasms
11
Leukemia, Lymphocytic, Chronic, B-Cell
9
Glioblastoma
9
Lymphoma, B-Cell, Marginal Zone
8
Burkitt Lymphoma
8
Brain Neoplasms
8
Sezary Syndrome
7
Neoplasms
7
Lymphoma, T-Cell, Cutaneous
7
Leukemia
7
Congenital Abnormalities
7
Unspecified Adult Solid Tumor, Protocol Specific
6
Recurrence
6
Neuroblastoma
6
Mycosis Fungoides
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Large-Cell, Anaplastic
6
Breast Neoplasms, Male
6
Sarcoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Interventions
Cisplatin
72
Brachytherapy
31
Radiotherapy
26
Paclitaxel
23
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
21
human papillomavirus vaccine, L1 type 16, 18
20
Topotecan
18
Papillomavirus Vaccines
18
Carboplatin
18
Surveys and Questionnaires
17
Bevacizumab
16
pembrolizumab
14
Radiation
12
Gemcitabine
12
Early Intervention, Educational
12
Colposcopy
12
Methods
11
Magnetic Resonance Spectroscopy
11
atezolizumab
10
Radiotherapy, Intensity-Modulated
10
Blood Specimen Collection
10
Papanicolaou Test
9
Docetaxel
9
Vaccines, Synthetic
8
Platinum
8
Nivolumab
8
Ipilimumab
8
Counseling
8
1,2-diaminocyclohexaneplatinum II citrate
8
Vaccines
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Uterine Cervical Neoplasms
×
Vorinostat
×
Clear all
NCT04357873
2025-02-19
PEVOsq
UNICANCER
Phase 2
Completed
112 enrolled